Respiration Disorders
68 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Narrower: Chronic Cough 1, Dyspnea 2, Mouth Breathing 2, Nasal Obstruction 1, Respiratory Aspiration 2, Respiratory Distress Syndrome 25, Respiratory Insufficiency 31
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| a wake prone positioning for respiratory distress syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| a wake prone positioning for respiratory insufficiency | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Apps for respiratory insufficiency | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Apremilast for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Apremilast for respiratory insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Atibuclimab for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Atibuclimab for respiratory insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Aviptadil for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Aviptadil for respiratory insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Awake prone positioning for respiratory distress syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Awake prone positioning for respiratory insufficiency | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Azithromycin for respiration disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Azithromycin for respiratory insufficiency | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Berobenatide for dyspnea | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Caspofungin for respiratory aspiration | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cenicriviroc for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cenicriviroc for respiratory insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Control for respiration disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cpap for respiratory insufficiency | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| CPAP + Dexamethasone for respiratory insufficiency | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cyclosporine for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cyclosporine for respiratory insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cyproheptadine for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cyproheptadine for respiratory insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dexamethasone for respiratory insufficiency | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dornase alfa for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dornase alfa for respiratory insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| EIT-Group for respiratory distress syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ENDS (Vaporizer/e-cig) and smoking cessation counseling for respiration disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Epidural spinal cord stimulation for respiratory insufficiency | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Exercise for respiration disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Famotidine + Celecoxib for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Famotidine + Celecoxib for respiratory insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Favipiravir for respiration disorders | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Hfno for respiratory insufficiency | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| HFNO + Dexamethasone for respiratory insufficiency | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Hydroxychloroquine for respiratory distress syndrome | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Hydroxychloroquine for respiratory insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Hydroxychloroquine + azithromycin + / - tocilizumab for respiratory insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Hydroxychloroquine Pill + Azithromycin Pill for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ibuprofen for respiratory distress syndrome | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Icatibant for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Icatibant for respiratory insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Imatinib Mesylate for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Imatinib Mesylate for respiratory insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Intermittent prone positioning instructions for respiratory insufficiency | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| LEAF-4L6715 for respiratory distress syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Mechanical ventilation with the automated BVM compressor for respiratory insufficiency | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Mefloquine for respiratory insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Mefloquine + azithromycin + / - tocilizumab for respiratory insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| myTAP oral appliance plus mouth shield for mouth breathing | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Nalbuphine for chronic cough | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Narsoplimab for respiratory distress syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Narsoplimab for respiratory insufficiency | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Oral Appliances for mouth breathing | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Oxymetazoline for nasal obstruction | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Prolonged Proned Positioning for respiratory insufficiency | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Prone decubitus for respiratory distress syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Prone Position for respiratory aspiration | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Prone Position for respiratory distress syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| prone positioning for respiratory distress syndrome | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Prone Positioning (PP) for respiratory distress syndrome | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Prone Positioning (PP) for respiratory insufficiency | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Proning for respiratory insufficiency | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Sildenafil Citrate for dyspnea | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Solizmestrocel for respiratory distress syndrome | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| UC-MSC and Secretome for respiratory distress syndrome | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Wharton's jelly derived Mesenchymal stem cells. for respiratory distress syndrome | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.